Cian Healthcare Ltd Financial Statements & Historical Data

Updated NSE: CHCLBSE: 542678
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 8 October 2026, 5:53 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price25.4₹ per share
Reported P/ENot availableTimes
Book value per share3.42₹ per share
Reported ROCE15.1 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 8 October 2026, 5:53 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap63.6 Cr.
Current Price25.4
High / Low25.4/4.72
Stock P/ENot available
Book Value3.42
Dividend Yield0.00 %
ROCE15.1 %
ROE49.2 %
Face Value10.0

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Cian Healthcare Ltd 63.6 Cr. 25.4 25.4/4.72 3.420.00 %15.1 %49.2 % 10.0
Vivimed Labs Ltd 58.3 Cr. 6.91 29.4/4.75 25.40.00 %65.2 %Not available 2.00
Fervent Synergies Ltd 74.4 Cr. 14.9 26.0/13.020.4 11.40.00 %7.21 %7.22 % 10.0
Mangalam Drugs and Organics Ltd 49.8 Cr. 31.5 74.0/22.7 65.30.00 %14.0 %34.8 % 10.0
Biofil Chemicals & Pharmaceuticals Ltd 49.5 Cr. 30.4 46.8/25.6103 13.20.00 %2.97 %2.83 % 10.0
Industry Average17,219.37 Cr1,223.5053.77211.240.39%26.16%16.59%6.06

All Competitor Stocks of Cian Healthcare Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricSep 2019Mar 2020Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Mar 2026
Sales 29283935473138313362191217
Expenses 26233428443032242851201720
Operating Profit 34573157411-1-5-3
OPM % 10%15%13%20%7%2.9%14%22%14%18%-8%-44%-18%
Other Income 01-00001000-120-13
Interest 4444333336210
Depreciation 2321223335222
Profit before tax -2-2-12-2-402-10-18-8-18
Tax % 0%17%23%28%7%-13%-167%14%37%-400%0%-0%0%
Net Profit -2-2-11-2-402-10-18-8-18
EPS in Rs -0.86-0.75-0.460.48-0.72-1.540.190.62-0.590.10-7.30-3.09-7.19

Last Updated: September 29, 2026, 7:46 am

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: February 27, 2026, 2:30 am

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Sales 577478696231
Expenses 506274565137
Operating Profit 71241311-7
OPM % 13%16%6%19%18%-21%
Other Income 10010-12
Interest 787663
Depreciation 434554
Profit before tax -41-620-26
Tax % 7%91%-8%-2%-1,600%-0%
Net Profit -40-621-26
EPS in Rs -1.620.02-2.210.810.34-10.39
Dividend Payout % -0%-0%-0%-0%-0%-0%

YoY Net Profit Growth

Year2020-20212022-20232023-20242024-2025
YoY Net Profit Growth (%)100.00%133.33%-50.00%-2700.00%
Change in YoY Net Profit Growth (%)0.00%33.33%-183.33%-2650.00%

Cian Healthcare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2020-2021 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:Not available
5 Years:Not available
3 Years:-6%
TTM:27%
Compounded Profit Growth
10 Years:Not available
5 Years:Not available
3 Years:53%
TTM:-8600%
Stock Price CAGR
10 Years:Not available
5 Years:-25%
3 Years:-43%
1 Year:-49%
Return on Equity
10 Years:Not available
5 Years:Not available
3 Years:-2%
Last Year:0%

Last Updated: September 5, 2025, 2:56 pm

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: August 11, 2026, 3:30 am

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 23232525252525
Reserves 35353032337-16
Borrowings 73716361565529
Other Liabilities 25284742476924
Total Liabilities 15715716616016115662
Fixed Assets 39375045393532
CWIP 2526131415156
Investments 5555550
Other Assets 8790989710210123
Total Assets 15715716616016115662
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + -7695122121
Cash from Investing Activity + -27313-1-013
Cash from Financing Activity + 36-10-11-7-10-4-50
Net Cash Flow 1-1-1-0-017-17
Free Cash Flow -26444112029
CFO/OP -99%49%197%37%106%-315%-296%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow-26.004.004.004.0011.0020.0029.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days 127.8093.56125.24139.58121.15
Inventory Days 267.18312.78299.94399.93485.99
Days Payable 220.03209.37270.46295.80371.29
Cash Conversion Cycle 174.95196.98154.73243.71235.85
Working Capital Days 14.7716.1438.3040.6626.27
ROCE %6.78%0.50%6.91%5.22%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthDec 2021Mar 2022Sep 2022Dec 2022Mar 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Sep 2025Mar 2026
Promoters 66.26%66.26%66.26%66.26%51.85%49.62%27.10%27.10%27.11%27.11%27.11%95.00%
DIIs 0.00%0.00%0.00%0.79%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Public 33.74%33.74%33.75%32.96%48.16%50.39%72.90%72.90%72.90%72.89%72.89%5.00%
No. of Shareholders 3963924244184546728808311,0881,5011,6621,683

This stock is not held by any mutual fund.

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) -10.390.100.81-2.320.02
Diluted EPS (Rs.) -10.390.100.81-2.320.02
Cash EPS (Rs.) -8.632.292.98-0.501.50
Book Value[Excl.RevalReserv]/Share (Rs.) 12.9523.1023.0022.1924.92
Book Value[Incl.RevalReserv]/Share (Rs.) 12.9523.1023.0022.1924.93
Revenue From Operations / Share (Rs.) 12.3224.6827.4431.1531.56
PBDIT / Share (Rs.) -2.574.525.201.915.17
PBIT / Share (Rs.) -4.332.343.030.203.69
PBT / Share (Rs.) -10.400.010.79-2.370.38
Net Profit / Share (Rs.) -10.390.100.81-2.210.02
NP After MI And SOA / Share (Rs.) -10.390.100.81-2.210.02
PBDIT Margin (%) -20.8918.3218.946.1416.37
PBIT Margin (%) -35.159.4611.030.6511.69
PBT Margin (%) -84.400.072.90-7.611.21
Net Profit Margin (%) -84.340.412.95-7.100.07
NP After MI And SOA Margin (%) -84.340.412.95-7.100.07
Return on Networth / Equity (%) -80.280.443.53-9.970.09
Return on Capital Employeed (%) -26.046.147.940.538.66
Return On Assets (%) -16.640.151.26-3.330.03
Long Term Debt / Equity (X) 0.210.470.510.680.64
Total Debt / Equity (X) 1.700.961.061.141.22
Asset Turnover Ratio (%) 0.190.380.440.430.49
Current Ratio (X) 0.611.091.141.141.10
Quick Ratio (X) 0.390.460.570.560.56
Inventory Turnover Ratio (X) 0.911.590.961.241.54
Interest Coverage Ratio (X) -2.211.952.280.741.56
Interest Coverage Ratio (Post Tax) (X) -3.711.041.340.151.03
Enterprise Value (Cr.) 45.84106.16129.47109.3294.69
EV / Net Operating Revenue (X) 1.491.721.891.401.28
EV / EBITDA (X) -7.129.399.9622.847.84
MarketCap / Net Operating Revenue (X) 0.270.831.020.610.35
Price / BV (X) 0.260.891.220.850.45
Price / Net Operating Revenue (X) 0.280.831.020.610.35
EarningsYield -3.010.000.02-0.110.00
Advertisements